SecBot SecBot
144 ·Filed Apr 15, 2026

MPLT

MapLight Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001974158-26-000049
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Traders should view this as a procedural, non-material event. The sale is not indicative of insider sentiment, as it is mandated by tax rules following RSU vesting. No follow-on selling should be expected based on this filing alone.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
MPLT ▲ +28.27% at T+60d
NEUTRAL call +28.27% · α vs SPY +21.22% · entry $28.51 → $36.57
Entry = T+0 close
Apr 15, 2026
via day close
T+1d
+5.40%
call +5.40% · α +4.19%
$30.05
settled 6mo ago
T+5d
+2.10%
call +2.10% · α +1.12%
$29.11
settled 6mo ago
T+20d
+7.58%
call +7.58% · α +1.76%
$30.67
settled 6mo ago
T+60d
+28.27%
call +28.27% · α +21.22%
$36.57
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Christopher Kroeger, an officer of MapLight Therapeutics, filed a Form 144 to notify intent to sell up to 14,844 shares of common stock, representing tax-withholding obligations from a restricted stock unit (RSU) vesting on July 30, 2023. This is a routine, non-discretionary sale to cover taxes, not a voluntary divestment.

Key Facts

  • Reporting owner: Christopher Kroeger, Officer of MapLight Therapeutics
  • Number of shares: 14,844 common shares
  • Purpose: Sale solely to satisfy tax-withholding obligations related to RSU vesting
  • Vesting date of underlying RSUs: July 30, 2023
  • Filing date: April 15, 2026
  • No indication of additional discretionary selling beyond tax obligations

Financial Impact

Approximately $56.3 million in gross transaction value (based on $3,800/share), but entire proceeds go to tax payments; no net financial benefit to insider

insider ownershiptax obligationsshare count

Risk Factors

  • Misinterpretation as voluntary insider selling, which could create false bearish sentiment
  • Potential short-term share supply increase if sale executes near-term

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001974158-26-000049
Document: 0001974158-26-000049-index.html0001974158-26-000049
Document: 0001974158-26-000049.txt0001974158-26-000049
31 reports for MPLT
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 6 of 7 best @ T+60▲ +57.24%May 18, 2026
Filters
Rows
Reports for MPLT — sortable, filterable
TypeNow
Oct 16, 2026
10d ago
Insider Cluster
BEARISH ★ 4/10
$8.00awaiting T+20—$7.66 (+4.25%)
Oct 15, 2026
11d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$7.66 (−0.52%)
Oct 15, 2026
11d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$7.66 (−0.52%)
Oct 15, 2026
11d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$7.66 (−0.52%)
Sep 24, 2026
4w ago
EFFECT
NEUTRAL ★ 4/10
$10.76 $8.25▼ −23.33%▼ −22.91%$7.66 (−28.81%)
Sep 18, 2026
5w ago
S-1/A
NEUTRAL ★ 4/10
$10.90 $8.00▼ −26.61%▼ −25.70%$7.66 (−29.72%)
Aug 4, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$12.92 $13.06▲ +1.08%▲ +1.69%$7.66 (−40.71%)
Aug 3, 2026
12w ago
144
NEUTRAL ★ 2/10
$12.94 $13.31▲ +2.86%▲ +4.10%$7.66 (−40.80%)
Jul 30, 2026
12w ago
144
BEARISH ★ 5/10
$13.02 $12.60▲ +3.23%▲ +6.21%$7.66 (+41.17%)
Jul 28, 2026
12w ago
Insider Buy
NEUTRAL ★ 3/10
$15.02 $12.86▼ −14.38%▼ −19.40%$7.66 (−49.00%)
Showing 10 of 31

US Market Status

Market Closed — Opens in 7h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026